The relationship between beta blockers and cancer is a subject of ongoing research. Several studies have investigated the potential role of beta blockers in cancer prevention and treatment. The interest in beta blockers stems from their ability to inhibit stress pathways that may contribute to cancer progression. Specifically, beta blockers target the beta-adrenergic receptors, which are involved in the body's response to stress and have been implicated in cancer cell proliferation, angiogenesis, and metastasis.
